Fidelity Investments
HOWL icon

Fidelity Investments’s Werewolf Therapeutics HOWL Stock Holding History

Fidelity Investments’s Portfolio HOWL Stock Details HOWL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-39
Closed -$32 – 5640
2026
Q1 		$32 Sell
39
-3,592
-99% -$2.46K ﹤0.01% 5323
2025
Q4 		$2.3K Sell
3,631
-7,653
-68% -$9.3K ﹤0.01% 5000
2025
Q3 		$22.2K Hold
11,284
– – ﹤0.01% 4312
2025
Q2 		$12.3K Buy
11,284
+6,823
+153% +$7.02K ﹤0.01% 4462
2025
Q1 		$4.34K Buy
4,461
+2,630
+144% +$3.44K ﹤0.01% 4743
2024
Q4 		$2.71K Buy
1,831
+317
+21% +$646 ﹤0.01% 4759
2024
Q3 		$3.21K Buy
1,514
+1,511
+50,367% +$3.44K ﹤0.01% 4713
2024
Q2 		$7 Buy
+3
New +$14 ﹤0.01% 5305
2023
Q3 		– Sell
-2,100
Closed -$6.41K – 5405
2023
Q2 		$6.41K Hold
2,100
– – ﹤0.01% 4285
2023
Q1 		$5.46K Buy
+2,100
New +$6.26K ﹤0.01% 4364
2022
Q4 		– Sell
-337,073
Closed -$1.52M – 5461
2022
Q3 		$1.52M Sell
337,073
-181,699
-35% -$987K ﹤0.01% 2507
2022
Q2 		$2.12M Buy
518,772
+137
+0% +$625 ﹤0.01% 2482
2022
Q1 		$2.28M Buy
518,635
+147,901
+40% +$1.04M ﹤0.01% 2566
2021
Q4 		$4.42M Buy
370,734
+132,234
+55% +$2M ﹤0.01% 2398
2021
Q3 		$4.09M Sell
238,500
-76,500
-24% -$1.31M ﹤0.01% 2414
2021
Q2 		$5.49M Buy
+315,000
New +$4.32M ﹤0.01% 2302

Other funds holding HOWL

RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $80.2B AUM 51.53% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
LCM
Lynx1 Capital Management San Juan, Puerto Rico $866M AUM 231.68% 1-Year Est. Return
SFM
Sphera Funds Management Tel Aviv, Israel $767M AUM 119.71% 1-Year Est. Return
DF
DC Funds Mclean, Virginia $1.25M AUM 26.51% 1-Year Est. Return
VA
Verdad Advisers Boston, Massachusetts $104M AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Fidelity Investments's HOWL Position: Q2 2026 in Review

Fidelity Investments sold out of Werewolf Therapeutics (HOWL) in Q2 2026, closing a stake of 39 shares — an estimated $32 sold.

Fidelity Investments first reported a position in HOWL in Q2 2021 and held it in 16 quarters. The position peaked at $5.49M in Q2 2021. 45 funds tracked by Wall St. Rank hold HOWL as of Q2 2026.

  • Fidelity Investments reported no remaining Werewolf Therapeutics position as of Q2 2026 after selling out during the quarter.
  • Fidelity Investments sold 39 Werewolf Therapeutics shares in Q2 2026, an estimated $32.
  • Fidelity Investments first reported a position in Werewolf Therapeutics in Q2 2021 and held it in 16 quarters.
  • Fidelity Investments's Werewolf Therapeutics position peaked at $5.49M in Q2 2021.
  • 45 funds tracked by Wall St. Rank held Werewolf Therapeutics as of Q2 2026.

Based on Fidelity Investments's 13F filing for Q2 2026, filed 13 Aug 2026.